Mastrodimou N - Search Results

1

Topically Administered NOX4 Inhibitor, GLX7013114, Is Efficacious in Treating the Early Pathological Events of Diabetic Retinopathy.

Dionysopoulou S, Wikstrom P, Bucolo C, Romano GL, Micale V, Svensson R, Spyridakos D, Mastrodimou N, Georgakis S, Verginis P, Walum E, Thermos K. Dionysopoulou S, et al. Among authors: mastrodimou n. Diabetes. 2023 May 1;72(5):638-652. doi: 10.2337/db22-0515. Diabetes. 2023. PMID: 36821829

2

Blockade of CB1 or Activation of CB2 Cannabinoid Receptors Is Differentially Efficacious in the Treatment of the Early Pathological Events in Streptozotocin-Induced Diabetic Rats.

Spyridakos D, Mastrodimou N, Vemuri K, Ho TC, Nikas SP, Makriyannis A, Thermos K. Spyridakos D, et al. Among authors: mastrodimou n. Int J Mol Sci. 2022 Dec 23;24(1):240. doi: 10.3390/ijms24010240. Int J Mol Sci. 2022. PMID: 36613692 Free PMC article.

3

The somatostatin receptor (sst1) modulates the release of somatostatin in rat retina.

Mastrodimou N, Thermos K. Mastrodimou N, et al. Neurosci Lett. 2004 Feb 6;356(1):13-6. doi: 10.1016/j.neulet.2003.11.020. Neurosci Lett. 2004. PMID: 14746890

4

The Synthetic Microneurotrophin BNN27 Affects Retinal Function in Rats With Streptozotocin-Induced Diabetes.

Ibán-Arias R, Lisa S, Mastrodimou N, Kokona D, Koulakis E, Iordanidou P, Kouvarakis A, Fothiadaki M, Papadogkonaki S, Sotiriou A, Katerinopoulos HE, Gravanis A, Charalampopoulos I, Thermos K. Ibán-Arias R, et al. Among authors: mastrodimou n. Diabetes. 2018 Feb;67(2):321-333. doi: 10.2337/db17-0391. Epub 2017 Dec 5. Diabetes. 2018. PMID: 29208634

5

Effect of acute and subchronic administration of (R)-WIN55,212-2 induced neuroprotection and anti inflammatory actions in rat retina: CB1 and CB2 receptor involvement.

Spyridakos D, Papadogkonaki S, Dionysopoulou S, Mastrodimou N, Polioudaki H, Thermos K. Spyridakos D, et al. Among authors: mastrodimou n. Neurochem Int. 2021 Jan;142:104907. doi: 10.1016/j.neuint.2020.104907. Epub 2020 Nov 19. Neurochem Int. 2021. PMID: 33220388

6

Effect of somatostatin analogues on chemically induced ischaemia in the rat retina.

Mastrodimou N, Lambrou GN, Thermos K. Mastrodimou N, et al. Naunyn Schmiedebergs Arch Pharmacol. 2005 Jan;371(1):44-53. doi: 10.1007/s00210-004-1011-9. Epub 2005 Jan 12. Naunyn Schmiedebergs Arch Pharmacol. 2005. PMID: 15645293

7

The role of nitric oxide and cGMP in somatostatin's protection against retinal ischemia.

Mastrodimou N, Kiagiadaki F, Thermos K. Mastrodimou N, et al. Invest Ophthalmol Vis Sci. 2008 Jan;49(1):342-9. doi: 10.1167/iovs.07-0341. Invest Ophthalmol Vis Sci. 2008. PMID: 18172111

8

Somatostatin receptors (sst2) regulate cGMP production in rat retina.

Mastrodimou N, Kiagiadaki F, Hodjarova M, Karagianni E, Thermos K. Mastrodimou N, et al. Regul Pept. 2006 Jan 15;133(1-3):41-6. doi: 10.1016/j.regpep.2005.09.034. Epub 2005 Nov 8. Regul Pept. 2006. PMID: 16280179

9

Effect of topical administration of the microneurotrophin BNN27 in the diabetic rat retina.

Ibán-Arias R, Lisa S, Poulaki S, Mastrodimou N, Charalampopoulos I, Gravanis A, Thermos K. Ibán-Arias R, et al. Among authors: mastrodimou n. Graefes Arch Clin Exp Ophthalmol. 2019 Nov;257(11):2429-2436. doi: 10.1007/s00417-019-04460-6. Epub 2019 Sep 12. Graefes Arch Clin Exp Ophthalmol. 2019. PMID: 31512044

10

Pasireotide (SOM230) protects the retina in animal models of ischemia induced retinopathies.

Kokona D, Mastrodimou N, Pediaditakis I, Charalampopoulos I, Schmid HA, Thermos K. Kokona D, et al. Among authors: mastrodimou n. Exp Eye Res. 2012 Oct;103:90-8. doi: 10.1016/j.exer.2012.08.005. Epub 2012 Sep 1. Exp Eye Res. 2012. PMID: 22960304

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

17 results

Search Page

Filters